К содержимому
learnspaceYOUR NEXT CHAPTER
ПРОСТРАНСТВО ОБУЧЕНИЯ
ГлавнаяКаталог курсовМоё обучениеCoursera

Знания без границ

Учитесь у лучших университетов и компаний мира.

Открыть Coursera
Интеграция
Пространство университета
Моё пространствоСтраница курса
↵
ЯЛичный кабинетСтудент
© 2026 LearnSpaceКаждый день — возможность узнать больше.Помощь
Drug Development · LearnSpace
Назад в каталог
courseraЗдоровье

Drug Development

Курс от University of California San Diego
Начальный≈ 9.7 чАнглийский
О курсеНавыкиПрограммаПреподаватели

О курсе

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.

Навыки, которые вы освоите

Drug DevelopmentClinical TrialsPre-Clinical DevelopmentClinical ResearchPharmaceuticalsRegulatory CompliancePatient SafetyCommercializationPharmacologyRegulatory Affairs

Программа курса

7 модулей · 56 учебных материалов

01Welcome!1 материалов

Lesson 1

Welcome!Видео
02Regulatory Considerations When Filing an Investigational New Drug Application, Susan Trieu, Pharm.D.11 материалов

Regulatory Considerations When Filing an Investigational New Drug Application Part I

Regulatory Considerations When Filing an Investigational New Drug Application IВидеоRegulatory Considerations When Filing an Investigational New Drug Application IIВидео

Учитесь у экспертов

Williams S. Ettouati, Pharm.D.

Managing Director, Master of Science in Drug Development & Product Management

Joseph D. Ma

Associate Professor of Clinical Pharmacy

Drug Development
В каталоге вашей программы

Инвестируйте в себя

Новые знания — в удобное для вас время.

Начать на Coursera

Обучение откроется на Coursera
в новой вкладке

Обучение на Coursera

≈ 9.7 ч

7 модулей

Язык: Английский

Субтитры: Арабский, Французский, Бенгальский, Украинский, Китайский (Китай), Греческий, Итальянский, Бразильский португальский, Вьетнамский, Нидерландский, Корейский, Немецкий, Пушту, Урду, Русский, Тайский, Индонезийский, Шведский, Турецкий, Азербайджанский, Испанский, Дари, Хинди, Японский, Казахский, Венгерский, Польский

Часть программы вашего университета
How do high user fees impact drug development?Обсуждение

Regulatory Considerations When Filing an Investigational New Drug Application Part II

Regulatory Considerations When Filing an Investigational New Drug Application IIIВидео Regulatory Considerations When Filing an Investigational New Drug Application IVВидеоRegulatory Considerations When Filing an Investigational New Drug Application VВидеоThe FDA's impact on drug development?Обсуждение

Review

Regulatory Considerations When Filing an Investigational New Drug Application QuizЗаданиеShare interesting findings from ClinicalTrials.govОбсуждениеLecture SlidesЧтение

Optional Materials

A new Master Degree in Science in Drug Development & Product Management at UCSDЧтение
03Clinical Study & Start-up Activities, Joseph Ma, Pharm.D.8 материалов

Clinical Study & Start-up Activities Part I

Clinical Study & Start-up Activities IВидеоClinical Study & Start-up Activities IIВидео

Clinical Study & Start-up Activities Part II

Clinical Study & Start-up Activities IIIВидеоWhat do you think are the most important ethical concerns?ОбсуждениеClinical Study & Start-up Activities IVВидеоClinical Study & Start-up Activities VВидео

Review

Clinical Study & Start-up Activities QuizЗаданиеLecture SlidesЧтение
04Clinical Trials: Phase 1, Yazdi Pithavala, Ph.D.8 материалов

Clinical Trials: Phase 1 Part I

Clinical Trials: Phase 1 Part IВидеоClinical Trials: Phase 1 Part IIВидео

Clinical Trials: Phase 1 Part II

Clinical Trials: Phase 1 Part IIIВидеоOther major safety Phase I situations?ОбсуждениеClinical Trials: Phase 1 Part IVВидеоClinical Trials: Phase 1 Part VВидео

Review

Clinical Trials: Phase 1 QuizЗаданиеLecture SlidesЧтение
05Clinical Trials: Phase 2, Kourosh Parivar, M.Pharm.8 материалов

Clinical Trials: Phase 2 Part I

Clinical Trials: Phase 2 Part IВидеоClinical Trials: Phase 2 Part IIВидео

Clinical Trials: Phase 2 Part II

Clinical Trials: Phase 2 Part IIIВидеоClinical Trials: Phase 2 Part IVВидеоClinical Trials: Phase 2 Part IVВидеоHow do you see changing medical technology impacting Phase II studies?Обсуждение

Review

Clinical Trials: Phase 2 QuizЗаданиеLecture SlidesЧтение
06Industry Considerations with Phase III Clinical Trials, Katie Lyons, Pharm.D. and Kelly Hogan, Pharm. D.10 материалов

Industry Considerations with Phase III Clinical Trials Part I

Industry Considerations with Phase III Clinical Trials IВидеоShare other globally influenced drug discoveries!ОбсуждениеIndustry Considerations with Phase III Clinical Trials IIВидеоShare a collaboration story...Обсуждение

Industry Considerations with Phase III Clinical Trials Part II

Industry Considerations with Phase III Clinical Trials IIIВидеоIndustry Considerations with Phase III Clinical Trials IVВидеоIndustry Considerations with Phase III Clinical Trials VВидеоWhat other values do you see in running studies in a variety of countries?Обсуждение

Review

Industry Considerations with Phase III Clinical Trials QuizЗаданиеLecture SlidesЧтение
07New Drug Application, Filing, Product Labeling, Kelly Hogan, Pharm.D.10 материалов

New Drug Application, Filing, Product Labeling Part I

New Drug Application, Filing, Product Labeling IВидеоNew Drug Application, Filing, Product Labeling IIВидеоNew Drug Application, Filing, Product Labeling IIIВидео

New Drug Application, Filing, Product Labeling Part II

New Drug Application, Filing, Product Labeling IVВидеоWhere do you get data on drugs?ОбсуждениеNew Drug Application, Filing, Product Labeling VВидеоDrug Promotion: Good or Bad?ОбсуждениеNew Drug Application, Filing, Product Labeling VIВидео

Review

New Drug Application, Filing, Product Labeling QuizЗаданиеLecture SlidesЧтение